Last reviewed · How we verify
NCT05063019
Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index
NA trial testing MRI in Hyperthermic Intraperitoneal Chemotherapy in 90 participants. Status unknown.
31 August 2024
Quick facts
| Lead sponsor | Chang Gung Memorial Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 90 |
| Start date | 1 September 2021 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- MRI — full drug profile →
Conditions studied
- Hyperthermic Intraperitoneal Chemotherapy — all drugs for Hyperthermic Intraperitoneal Chemotherapy →
- Cytoreductive Surgery — all drugs for Cytoreductive Surgery →
- Peritoneal Carcinomatosis — all drugs for Peritoneal Carcinomatosis →
Sponsor
Chang Gung Memorial Hospital
Who can join
Adults 20 to 80, any sex, with Hyperthermic Intraperitoneal Chemotherapy or Cytoreductive Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective observational study which will recruit 90 participants over a three-year period to investigate whether adding magnetic resonance imaging and enterography to routine computed tomography study can better predict the extend of peritoneal carcinomatosis over computed tomography alone.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mechanism and role of ferroptosis in the development of gastric cancer.
Wei F, Meng Y, Zhu DX, Wu J. · · 2025 · cited 1× · PMID 40439806 · DOI 10.1007/s10238-025-01722-y
Verify or expand the search:
- PubMed search for NCT05063019
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MRI
Trials testing the same drug.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
- NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
- NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
- NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting
Other recruiting trials for Hyperthermic Intraperitoneal Chemotherapy
Currently open trials in the same condition.
- NCT06946901 — The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Per · Phase 2 · recruiting
Other Chang Gung Memorial Hospital trials
Trials by the same sponsor.
- NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
- NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
- NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
- NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
- NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05063019 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
- Last refreshed: 18 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05063019.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing